These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8737229)
1. Effects of recombinant human erythropoietin in infants with very low birth weights. Samanci N; Ovali F; Dagoglu J Int Med Res; 1996; 24(2):190-8. PubMed ID: 8737229 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933 [TBL] [Abstract][Full Text] [Related]
5. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627 [TBL] [Abstract][Full Text] [Related]
6. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants. Carnielli VP; Da Riol R; Montini G Arch Dis Child Fetal Neonatal Ed; 1998 Jul; 79(1):F44-8. PubMed ID: 9797624 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin in anemia of prematurity. Whitehall JS; Patole SK; Campbell P Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin in the treatment of anemia of prematurity. Chen JY; Wu TS; Chanlai SP Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930 [TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human erythropoietin on transfusion needs in preterm infants. Yeo CL; Choo S; Ho LY J Paediatr Child Health; 2001 Aug; 37(4):352-8. PubMed ID: 11532054 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia. Giannakopoulou C; Bolonaki I; Stiakaki E; Dimitriou H; Galanaki H; Hatzidaki E; Kalmanti M Pediatr Hematol Oncol; 1998; 15(1):37-43. PubMed ID: 9509504 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity. Bechensteen AG; Hågå P; Halvorsen S; Whitelaw A; Liestøl K; Lindemann R; Grøgaard J; Hellebostad M; Saugstad OD; Grønn M Arch Dis Child; 1993 Jul; 69(1 Spec No):19-23. PubMed ID: 8346946 [TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns. Siddappa AM; Olson RM; Spector M; Northrop E; Zamora T; Brearley AM; Georgieff MK; Rao R J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819 [TBL] [Abstract][Full Text] [Related]
13. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. Carnielli V; Montini G; Da Riol R; Dall'Amico R; Cantarutti F J Pediatr; 1992 Jul; 121(1):98-102. PubMed ID: 1625101 [TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants. Akisu M; Tuzun S; Arslanoglu S; Yalaz M; Kultursay N Acta Med Okayama; 2001 Dec; 55(6):357-62. PubMed ID: 11779098 [TBL] [Abstract][Full Text] [Related]
15. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake. Bechensteen AG; Hågå P; Halvorsen S; Liestøl K; Lindemann R; Whitelaw A; Tølløfsrud PA; Daae L; Thorstensen K; Sundal E Eur J Pediatr; 1997 Jan; 156(1):56-61. PubMed ID: 9007493 [TBL] [Abstract][Full Text] [Related]
16. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. Al-Kharfy T; Smyth JA; Wadsworth L; Krystal G; Fitzgerald C; Davis J; Milner R J Pediatr; 1996 Jul; 129(1):89-96. PubMed ID: 8757567 [TBL] [Abstract][Full Text] [Related]
17. Early treatment of premature infants with recombinant human erythropoietin. Messer J; Haddad J; Donato L; Astruc D; Matis J Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820 [TBL] [Abstract][Full Text] [Related]
18. Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease. Zuppa AA; Maragliano G; Scapillati ME; Florio MG; Girlando P; Noia G; De Santis M; Cavaliere AF; Romagnoli C; Tortorolo G Fetal Diagn Ther; 1999; 14(5):270-4. PubMed ID: 10529568 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577 [TBL] [Abstract][Full Text] [Related]
20. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. Ohls RK; Harcum J; Schibler KR; Christensen RD J Pediatr; 1997 Nov; 131(5):661-5. PubMed ID: 9403642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]